Argenx Se ARGX
NASDAQ ARGX
$1,036.08 -17.38 (-1.65%)
As of: Sep 4, 2026 · 2:21 PM EDT

Argenx Se (ARGX) Enterprise Value (2017 - 2026)

Argenx Se's (ARGX) quarterly Enterprise Value came in at -$5.2 billion in Q2 2026, up 99.55% YoY from -$2.6 billion in Q2 2025, and down 16.76% on a QoQ basis from -$4.4 billion in Q4 2025.

Analysis

Argenx Se (ARGX) Enterprise Value (2017 - 2026) Analysis & Trends

Argenx Se (ARGX) has 12 years of Enterprise Value data on file, last reported at -$5.2 billion in Q2 2026.

  • Quarterly Enterprise Value rose 99.55% year-over-year to -$5.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5.2 billion (up 99.55% YoY) and the FY2025 annual result came in at -$5.9 billion, down 960.14% from the prior year.
  • Enterprise Value slipped to -$5.2 billion in Q2 2026, from -$4.4 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $1107.0 billion in Q2 2024 to a low of -$1156.3 billion in Q2 2025.
  • A 5-year average of -$8.0 billion and a median of -$3.2 billion in 2023 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2024 — Enterprise Value surged 55532.62% — and 2025, when it plunged 204.46%.
  • Tracing ARGX's Enterprise Value over 5 years: stood at -$2.2 billion in 2022, then slumped by 45.03% to -$3.2 billion in 2023, then fell by 6.26% to -$3.4 billion in 2024, then sank by 31.4% to -$4.4 billion in 2025, then fell by 16.76% to -$5.2 billion in 2026.
  • The last three Enterprise Value figures came in at -$5.2 billion (Q2 2026), -$4.4 billion (Q4 2025), and -$1156.3 billion (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn
10 Incyte 25.64 Bn 21.11 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.23 Bn
Mar 31, 2026 45.19 Bn
Dec 31, 2025 47.60 Bn
Sep 30, 2025 44.81 Bn
Jun 30, 2025 30.25 Bn
Mar 31, 2025 35.96 Bn
Dec 31, 2024 -1,843.02 Bn
Sep 30, 2024 32.09 Bn
Jun 30, 2024 1,132.43 Bn
Mar 31, 2024 23.31 Bn
Dec 31, 2023 19.34 Bn
Sep 30, 2023 27.23 Bn
Jun 30, 2023 19.59 Bn
Mar 31, 2023 20.64 Bn
Dec 31, 2022 -1,371.62 Bn
Sep 30, 2022 18.24 Bn
Jun 30, 2022 16.98 Bn
Mar 31, 2022 16.29 Bn
Dec 31, 2021 -985.29 Bn
Sep 30, 2021 14.37 Bn